Humatica AG was retained to advise Capvis on its majority investment in Austrian firm AMANN GIRRBACH AG, a pioneer in dental CAD/CAM technology. The firm is a leading innovator in the field and a full-service provider for digital dental prosthetics.
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica advises Capvis on their recent investment in AMANN GIRRBACH
Zurich, 10 July 2024 – Humatica realized unprecedented 89% fee revenue growth in the first half of 2024. Increased professional fees came from both recurring and…
Read moreLondon, 28 May 2024 – Humatica has officially been named as one of the UK’s Best Workplaces for Development™ 2024 by Great Place To Work®,…
Read moreHumatica is proud to announce being recognized as one of only 24 “gold” ranked change management consultants in the UK by consultancy.uk. The UK is…
Read more